Entresto is available in multiple strengths to suit individual patient needs. These strengths refer to the dosage of the active pharmaceutical ingredients it contains.
What are the specific strengths of Entresto?
Entresto contains a combination of sacubitril and valsartan. The available strengths are typically expressed in terms of milligrams (mg) for each component. Common dosages include:
* 24 mg sacubitril / 26 mg valsartan [1]
* 49 mg sacubitril / 51 mg valsartan [1]
* 97 mg sacubitril / 103 mg valsartan [1]
These different strengths allow healthcare providers to tailor treatment regimens for patients with heart failure.
How is Entresto prescribed and what dosage is right for me?
The appropriate strength of Entresto is determined by a physician based on a patient's medical condition, kidney function, and previous treatments. It is often initiated at a lower dose and gradually increased to the target dose, provided the patient tolerates it well [2]. For example, patients transitioning from an ACE inhibitor or ARB might start on a lower strength, while those not on these medications could begin with a higher dose [2].
When does Entresto patent protection expire?
The patent landscape for Entresto is complex, with multiple patents covering different aspects of the drug, including its composition, methods of use, and manufacturing processes. DrugPatentWatch.com provides detailed information on these patents and their expiration dates. Understanding patent expirations is crucial for anticipating the potential market entry of generic alternatives [3].
Are there alternatives to Entresto for heart failure treatment?
Several other medications are used to treat heart failure, depending on the specific type of heart failure and patient characteristics. These can include other angiotensin receptor-neprilysin inhibitors (ARNIs), angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), beta-blockers, and mineralocorticoid receptor antagonists (MRAs) [4].
What are the main side effects of Entresto?
Common side effects associated with Entresto can include hypotension (low blood pressure), hyperkalemia (high potassium levels), increased serum creatinine, dizziness, and cough [1][2]. Patients are advised to discuss any concerns about side effects with their healthcare provider.
How does Entresto work?
Entresto belongs to a class of drugs called angiotensin receptor-neprilysin inhibitors (ARNIs). It works by blocking the effects of certain hormones in the body that can worsen heart failure. Specifically, it inhibits neprilysin, an enzyme that breaks down natriuretic peptides, which help the body get rid of salt and water and widen blood vessels. It also blocks the angiotensin II receptor [1][4]. This dual action helps reduce the strain on the heart.
What is the difference between Entresto and other heart failure medications?
Entresto's unique mechanism of action as an ARNI differentiates it from older classes of heart failure medications like ACE inhibitors and ARBs. By inhibiting neprilysin, Entresto enhances the beneficial effects of natriuretic peptides, which is a pathway not targeted by ACE inhibitors or ARBs alone [4]. Clinical studies have shown Entresto to be more effective than enalapril (an ACE inhibitor) in reducing cardiovascular death and heart failure hospitalization in certain patient populations [4].
Who manufactures Entresto?
Entresto is manufactured by Novartis [5].
Sources:
1. "Entresto (sacubitril/valsartan) Dosing, Side Effects, Dosage, Interactions & Warnings - Drugs.com." Drugs.com, www.drugs.com/dosage/entresto.html. Accessed 25 May 2024.
2. "Entresto prescribing information." Novartis Pharmaceuticals Corporation, www.pharma.us.novartis.com/sites/default/files/entresto.pdf. Accessed 25 May 2024.
3. "Entresto Drug Patent & Exclusivity Information." DrugPatentWatch.com, www.drugpatentwatch.com/entresto. Accessed 25 May 2024.
4. "Sacubitril/Valsartan (Entresto)." Cleveland Clinic, my.clevelandclinic.org/health/drugs/21914-sacubitrilvalsartan-entresto. Accessed 25 May 2024.
5. "Entresto." Novartis, www.novartis.com/our-impact/products/entresto. Accessed 25 May 2024.